Cite

HARVARD Citation

    Ponomareva, O. et al. (2020). L-Tetrahydropalmatine, a Novel Dopamine Antagonist, Fails to Improve Psychiatric Symptoms as Adjunctive Treatment for Schizophrenia. Schizophrenia bulletin open. 1 (1), p. . [Online]. 
  
Back to record